Real-life experience of tocilizumab use in COVID-19 patients. (2020)

First Author: Madenidou AV
Attributed to:  MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keaa325

PubMed Identifier: 32556278

Publication URI: http://europepmc.org/abstract/MED/32556278

Type: Journal Article/Review

Volume: 59

Parent Publication: Rheumatology (Oxford, England)

Issue: 8

ISSN: 1462-0324